Stem cells and experimental leukemia can be distinguished by lipid raft protein composition

Stem Cells and Development

Volumn 15, Issue 5, 2006, Pages 677-686

  Osterhues, Anja ^a,b   Liebmann, Sibylle ^a   Schmid, Monika ^c   Buk, Deborah ^b   Huss, Ralf ^a,d   Graeve, Lutz ^b   Zeindl Eberhart, Evelyn ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HOHENHEIM   (Germany)

^c MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^d ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; FLOTILLIN 1; GALECTIN 3; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HLA DR2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MOLECULAR MARKER; RAFT ASSOCIATED PROTEIN; UNCLASSIFIED DRUG; VIMENTIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; GENETIC TRANSFECTION; LEUKEMIA; LIPID RAFT; MAJOR HISTOCOMPATIBILITY COMPLEX; MALIGNANT TRANSFORMATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR CLONING; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SCID MOUSE; STEM CELL; TUMOR GROWTH;

ANIMALS; CAVEOLIN 1; CELL TRANSFORMATION, NEOPLASTIC; DOGS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; LEUKEMIA, EXPERIMENTAL; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; MICE; PROTEOME; STEM CELLS;

EID: 33750976691     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2006.15.677     Document Type: Article

References (44)

1. Huss R, DS Hong, PA McSweeney, CA Hoy and HJ Deeg. (1995). Differentiation of canine bone marrow cells with hemopoietic characteristics from an adherent stromal cell precursor. Proc Natl Acad Sci USA 92:748-752.
2. Huss R, CA Hoy and HJ Deeg. (1995). Contact- and growth factor-dependent survival in a canine marrow-derived stromal cell line. Blood 85:2414-2421.
3. Huss R, DH Myerson and HJ Deeg. (1997). Haematopoietic progenitor cells transfected with a differentiation antigen show cellular transformation and tumour growth in mice. Int J Exp Pathol 78:177-185.
4. Huss R, EM Weissinger, C Lange, P Gatsios, G Eissner, HJ KolbJ, J Diebold, PC Heinrich and L Graeve. (2000). In vitro-generated stem cell leukaemia showing altered cell cycle progression with distinct signalling of the tyrosinephosphorylated rasGAP-associated p62(dok) protein. J Pathol 192:363-372.
5. Huss R, S Theis and HJ Deeg. (1999). CDK-inhibitor independent cell cycle progression in an experimental haematopoietic stem cell leukaemia despite unaltered Rb-phosphorylation. Br J Cancer 81:808-813.
6. Sgambato A, YJ Zhang, N Arber, H Hibshoosh, Y Doki, M Ciaparrone, RM Santella, A Cittadini and IB Weinstein. (1997). Deregulated expression of p27(Kip1) in human breast cancers. Clin Cancer Res 3:1879-1887.
7. Morosetti R, N Kawamata, AF Gombart, CW Miller, Y Hatta, T Hirama, JW Said, M Tomonaga and HP Koeffler. (1995). Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood 86:1924-1930.
8. Huby RD, RJ Dearman and I Kimber. (1999). Intracellular phosphotyrosine induction by major histocompatibility complex class II requires co-aggregation with membrane rafts. J Biol Chem 274:22591-22596.
9. Simons K and E Ikonen. (1997). Functional rafts in cell membranes. Nature 387:569-572.
10. Galbiati F, B Razan and MP Lisanti. (2001). Emerging themes in lipid rafts and caveolae. Cell 106:403-411.
11. Brown DA and E London. (1998). Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 14:111-136.
12. Simons K and D Toomre. (2000). Lipid rafts and signal transduction. Nature Rev Mol Cell Biol 1:31-39.
13. Anderson RG. (1998). The caveolae membrane system. Annu Rev Biochem 67:199-225.
14. Simons K and R Ehehalt. (2002). Cholesterol, lipid rafts, and disease. J Clin Invest 110:597-603.
15. Scheiffele P, P Verkade, AM Fra, H Virta, K Simons and E Ikonen. (1998). Caveolin-1 and -2 in the exocytic pathway of MDCK cells. J Cell Biol 140:795-806.
16. von Haller PD, S Donohoe, DR Goodlett, R Aebersold and JD Watts. (2001). Mass spectrometric characterization of proteins extracted from Jurkat T cell detergent-resistant membrane domains. Proteomics 1:1010-1021.
17. Zeindl-Eberhart E, PR Jungblut and HM Rabes. (1997). A new method to assign immunodetected spots in the complex two-dimensional electrophoresis pattern. Electrophoresis 18:799-801.
18. Klose J. (1999). Fractionated extraction of total tissue proteins from mouse and human for 2-D electrophoresis. Methods Mol Biol 112:67-85.
19. Zeindl-Eberhart E and HM Rabes. (1992). Variant protein patterns in hepatomas and transformed liver cell lines as determined by high resolution two-dimensional gel electrophoresis (2DE). Carcinogenesis 13:1177-1183.
20. Jungblut PR and R Seifen. (1990). Analysis by high-resolution two-dimensional electrophoresis of differentiation-dependent alterations in cytosolic protein pattern of HL-60 leukemic cells. J Biochem Biophys Methods 21:47-58.
21. Lamer S and PR Jungblut. (2001). Matrix-assisted laser desorption-ionization mass spectrometry peptide mass finger-printing for proteome analysis: identification efficiency after on-blot or in-gel digestion with and without desalting procedures. J Chromatogr B Biomed Sci Appl 752:311-322.
22. London E and DA Brown. (2000). Insolubility of lipids in triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). Biochim Biophys Acta 1508:182-195.
23. Schuck S, M Honsho, K Ekroos, A Shevchenko and K Simons. (2003). Resistance of cell membranes to different detergents. Proc Natl Acad Sci USA 100:5795-5800.
24. Roepstorff K, P Thomsen, K Sandvig and B van Deurs. (2002). Sequestration of epidermal growth factor receptors in non-caveolar lipid rafts inhibits ligand binding. J Biol Chem 277:18954-18960.
25. Roper K, D Corbeil and WB Huttner. (2000). Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nature Cell Biol 2:582-592.
26. Buk DM, M Waibel, C Braig, AS Martens, PC Heinrich and L Graeve. (2004). Polarity and lipid raft association of the components of the ciliary neurotrophic factor complex in Madin-Darby canine kidney cells. J Cell Sci 117: 2063-2075.
27. Harder T, P Scheiffele, P Verkade and K Simons. (1998). Lipid domain structure of the plasma membrane revealed by patching of membrane components. J Cell Biol 141:929-942.
28. Mayor S and FR Maxfield. (1995). Insolubility and redistribution of GPI-anchored proteins at the cell surface after detergent treatment. Mol Biol Cell 6:929-944.
29. Koleske AJ, D Baltimore and MP Lisanti. (1995). Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci USA 92:1381-1385.
30. Galbiati F, D Volonte, JA Engelman, G Watanabe, R Burk, RG Pestell and MP Lisanti. (1998). Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 17:6633-6648.
31. Engelman JA, CC Wykoff, S Yasuhara, KS Song, T Okamoto and MP Lisanti. (1997). Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biol Chem 272:16374-16381.
32. Bickel PE, PE Scherer, JE Schnitzer, P Oh, MP Lisanti and HF Lodish. (1997). Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J Biol Chem 272:13793-13802.
33. Li N, A Mak, DP Richards, C Naber, BO Keller, L Li and AR Shaw. (2003). Monocyte lipid rafts contain proteins implicated in vesicular trafficking and phagosome formation. Proteomics 3:536-548.
34. Sprenger RR, D Speijer, JW Back, CG De Koster, H Pannekoek and AJ Horrevoets. (2004). Comparative proteomics of human endothelial cell caveolae and rafts using two-dimensional gel electrophoresis and mass spectrometry. Electrophoresis 25:156-172.
35. Runembert I, G Queffeulou, P Federici, F Vrtovsnik, E Colucci-Guyon, C Babinet, P Briand, G Trugnan, G Friedlander and F Terzi. (2002). Vimentin affects localization and activity of sodium-glucose cotransporter SGLT1 in membrane rafts. J Cell Sci 115:713-724.
36. Inagaki M, Y Nishi, K Nishizawa, M Matsuyama and C Sato. (1987). Site-specific phosphorylation induces disassembly of vimentin filaments in vitro. Nature 328:649-652.
37. Paramio JM and JL Jorcano. (2002). Beyond structure: do intermediate filaments modulate cell signalling? Bioessays 24:836-844.
38. Dellagi K, A Tabilio, MM Portier, W Vainchenker, S Castaigne, J Guichard, J Breton-Gorius and JC Brouet. (1985). Expression of vimentin intermediate filament cytoskeleton in acute nonlymphoblastic leukemias. Blood 65:1444-1452.
39. Eiden MV, L MacArthur and H Okayama. (1991). Suppression of the chemically transformed phenotype of BHK cells by a human cDNA. Mol Cell Biol 11:5321-5329.
40. Lin HM, RG Pestell, A Raz and HR Kim. (2002). Galectin-3 enhances cyclin D(1) promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells. Oncogene 21:8001-8010.
41. Tatton WG, RM Chalmers-Redman, M Elstner, W Leesch, FB Jagodzinski, DP Stupak, MM Sugrue and NA Tatton. (2000). Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling. J Neural Transm Suppl 60:77-100.
42. Rondinelli RH, DE Epner and JV Tricoli. (1997). Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in late pathological stage human prostate cancer. Prostate Cancer Prostatic Dis 1:66-72.
43. Sirover MA. (1999). New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta 1432:159-184.
44. Sunaga K, H Takahashi, DM Chuang and R Ishitani. (1995). Glyceraldehyde-3-phosphate dehydrogenase is over-expressed during apoptotic death of neuronal cultures and is recognized by a monoclonal antibody against amyloid plaques from Alzheimer's brain. Neurosci Lett 200:133-136.